at 2153 has been researched along with uridine in 1 studies
| Studies (at 2153) | Trials (at 2153) | Recent Studies (post-2010) (at 2153) | Studies (uridine) | Trials (uridine) | Recent Studies (post-2010) (uridine) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 12,749 | 69 | 1,083 |
| Protein | Taxonomy | at 2153 (IC50) | uridine (IC50) |
|---|---|---|---|
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.8 | |
| Solute carrier family 28 member 3 | Homo sapiens (human) | 5.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, GD; Liu, TX; Wang, MY; Zhang, TM | 1 |
1 other study(ies) available for at 2153 and uridine
| Article | Year |
|---|---|
[Effects of bimolane and probimane on the incorporation of (3H)TdR, (3H)UR and (3H)Leu into Ehrlich ascites carcinoma cells iv vitro].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; DNA, Neoplasm; Female; Leucine; Male; Mice; Piperazines; Razoxane; RNA, Neoplasm; Thymidine; Tumor Cells, Cultured; Uridine | 1988 |